购物车
- 全部删除
- 您的购物车当前为空
PD-L1 Protein, Human, Recombinant (CHO, hFc) is expressed in CHO Cells. The accession number is Q9NZQ7-1.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
50 μg | ¥ 1,720 | 5日内发货 | |
1 mg | ¥ 17,200 | 5日内发货 |
生物活性 | Assay #1: Immobilized PD-L1, hFc, Human at 1.0 μg/ml (100 μl/well) can bind biotinylated PD-1, hFc, Human (Cat.No.: Z03370). Assay #2: Immobilized PD-1, His, Human(Cat.No.: Z03424) at 2.0 μg/ml can bind PD-L1, hFc, Human. |
产品描述 | PD-L1 Protein, Human, Recombinant (CHO, hFc) is expressed in CHO Cells. The accession number is Q9NZQ7-1. |
种属 | Human |
表达系统 | CHO Cells |
标签 | hFc |
蛋白编号 | Q9NZQ7-1 |
别名 | Programmed cell death ligand 1,PDL1,PDCD1LG1,PDCD1L1,CD274 molecule,CD274,B7-H1,B7-H |
蛋白构建 | Phe19-Thr239 |
蛋白纯度 | > 98% as determined by SDS-PAGE |
分子量 | 70~72 kDa (Reducing conditions) |
内毒素 | < 0.2 EU/μg of protein as determined by the LAL method. |
缓冲液 | Lyophilized from a 0.2 μm filtered solution in PBS |
复溶方法 | Reconstitute the lyophilized protein in sterile deionized water. The product concentration should not be less than 100 μg/ml. Before opening, centrifuge the tube to collect powder at the bottom. After adding the reconstitution buffer, avoid vortexing or pipetting for mixing. |
存储 | Upon receiving, this product remains stable for up to 6 months at lower than -70°C. Upon reconstitution, the product should be stable for up to 1 week at 4°C or up to 3 months at -20°C. For long term storage it is recommended that a carrier protein (example 0.1% BSA) be added. Avoid repeated freeze-thaw cycles. |
运输方式 | In general, Lyophilized powders are shipping with blue ice. Solutions are shipping with dry ice. |
研究背景 | Programmed death-ligand 1 (PD-L1) also known as cluster of differentiation 274 (CD274) or B7 homolog 1 (B7-H1), is a protein that in humans is encoded by the CD274 gene. PD-L1 is a 40 kDa type 1 transmembrane protein that has been speculated to play a major role in suppressing the immune system during particular events such as pregnancy, tissue allografts, autoimmune disease and other disease states such as hepatitis. Normally the immune system reacts to foreign antigens where there is some accumulation in the lymph nodes or spleen which triggers a proliferation of antigen-specific CD8 + T cell. The formation of PD-1 receptor / PD-L1 or B7.1 receptor /PD-L1 ligand complex transmits an inhibitory signal which reduces the proliferation of these CD8 + T cells at the lymph nodes and supplementary to that PD-1 is also able to control the accumulation of foreign antigen specific T cells in the lymph nodes through apoptosis which is further mediated by a lower regulation of the gene Bcl-2. PD-L1 binds to its receptor, PD-1, found on activated T cells, B cells, and myeloid cells, to modulate activation or inhibition. Recombinant Human PD-L1(B7-H1) Fc Chimera produced in CHO cells is a polypeptide chain containing 457 amino acids. A fully biologically active molecule, rh PD‑L1(B7-H1) has a molecular mass of 70-72 kDa analyzed by reducing SDS-PAGE and is obtained by chromatographic techniques at GenScript. |